Prulifloxacin Pages on BioPortfolio:

BioPortfolio - Prulifloxacin
Biotechnology News biotechnology pharmaceutical prulifloxacin . ... BioPortfolio - Prulifloxacin BioPortfolio Biotechnology Pharmaceutical Healthcare ...
http://www.bioportfolio.com/search/Prulifloxacin.html...

...

BioPortfolio - Shanghai Children s Medical Center 2008 abbott
BioPortfolio - Prulifloxacin pain | pain and 2008 | back pain | Shanghai Children s Medical ... http://www.bioportfolio.com/search/Prulifloxacin.html.
...
http://www.bioportfolio.com/search/Shanghai_Children_s_Medic...

...

BioPortfolio - MEDICALLY INDUCED ABORTION DORSET
BioPortfolio - Prulifloxacin BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life ... http://www.bioportfolio.com/search/Prulifloxacin.
html. ...
http://www.bioportfolio.com/search/MEDICALLY_INDUCED_ABORTIO...

...

BioPortfolio - Optimer Pharmaceuticals
Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study SAN DIEGO--(BUSINESS WIRE)--Optimer Pharmaceuticals, Inc. . ...
http://www.bioportfolio.com/search/Optimer_Pharmaceuticals.h...

...

BioPortfolio - Pelvic Infection research
[Antibiotic prophylaxis with prulifloxacin in women undergoing induced abortion: a randomized controlled trial], 28th June, 2008 ...
http://www.bioportfolio.com/indepth/Pelvic_Infection/researc...

...

Results from other life science and pharmaceutical sites:

[Clinical study of prulifloxacin on infectious ent ...
Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis] ... Prulifloxacin (PUFX), a new quinolone antimicrobial agent, ...
http://www.ncbi.nlm.nih.gov/pubmed/8797308...

Optimer Pharmaceuticals, Inc. Announces Positive Results in ...
16 Jul 2008 ... The median TLUS for patients treated with Prulifloxacin was ... Prulifloxacin was generally well tolerated and had a similar safety profile ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103431...

[Antibiotic prophylaxis with prulifloxacin in wome...[Minerva ...
AIM: To verify the efficacy of prulifloxacin in prevention of infective morbidity in women undergoing first trimester induced abortion. ...
http://www.ncbi.nlm.nih.gov/pubmed/18277346...

News: Optimer Pharmaceuticals Completes Enrollment in Second ...
2 Sep 2008 ... The Company previously reported positive top-line data from the first Phase 3 trial which showed that Prulifloxacin met the primary endpoint ...
http://www.genengnews.com/news/bnitem.aspx?name=41214058&tax...

Prulifloxacin. [Drugs. 2004] - PubMed Result
Prulifloxacin, the prodrug of ulifloxacin, is a broad-spectrum oral ... After absorption, prulifloxacin is metabolised by esterases to ulifloxacin. ...
http://www.ncbi.nlm.nih.gov/pubmed/15456336...

In vitro activity of prulifloxacin against Escheri...[Int J ...
In terms of MIC(90), prulifloxacin was more potent than ciprofloxacin and levofloxacin ... Therapeutic effect of the quinolone prodrug prulifloxacin
against ...
http://www.ncbi.nlm.nih.gov/pubmed/17363225...

Optimer Products Face Competition: Financial News - Yahoo! Finance
The company has two phase III drug candidates: Difimicin for Clostridium difficile-associated diarrhea (CDAD), and Prulifloxacin for infectious diarrhea.
...
http://biz.yahoo.com/zacks/080813/14195.html?.v=1...

Prulifloxacin versus ciprofloxacin in the treatmen...[Urol Int ...
CONCLUSIONS: The high urinary concentrations of prulifloxacin, ... Prulifloxacin : a new fluoroquinolone for the treatment of acute exacerbation of chronic ...
http://www.ncbi.nlm.nih.gov/pubmed/15897698...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.